
Top AI companies, including OpenAI and Anthropic, have signed a letter urging Congress to implement laws to prevent AI from being used to develop biological weapons. The letter, organized by the Institute for Progress and the Foundation for American Innovation, warns that AI advancements could lower the barriers to creating such weapons. It calls for mandatory screening of synthetic DNA and RNA orders to prevent misuse. This initiative highlights the growing concern over AI's potential role in bioterrorism and the need for regulatory measures to mitigate these risks.
Read originalEarlier coverage that leads up to this article, and what followed. Lines connect each piece to the closest one after it, converging here.
© TechCrunch AIxAI's attempt to dismiss the NAACP's Clean Air Act lawsuit failed after a federal judge ruled that its gas turbines are not exempt mobile sources and that plaintiffs have standing. This legal setback confirms that AI infrastructure operators cannot bypass environmental permitting by classifying heavy industrial equipment as temporary or mobile. The ruling forces xAI to face scrutiny over air quality impacts at its Colossus data center, setting a precedent for how large-scale compute facilities are regulated under existing environmental laws.
© TechCrunch AIAI Explained · March 26, 2026 · Background
The Verge AI · May 26, 2026 · Background
OpenAI · June 3, 2026 · Background
OpenAI · June 4, 2026 · Related
The Verge AI · July 28, 2026 · Related
TechCrunch AI · August 27, 2026 · Related
The Rundown AI · September 14, 2026 · Related
WIRED AI · September 14, 2026 · Related
WIRED AI · September 18, 2026 · Related
AI Firms Urge Congress to Regulate Bioweapon Risks
2 developments
OpenAI is scaling back its ambitions as investor appetite for massive AI infrastructure bets cools. The company has lowered its fundraising target from $30 billion to $20 billion, with only $11 billion secured so far against a valuation that has dropped from $1.4 trillion. This retreat signals a growing wariness among Wall Street investors regarding the capital intensity of the AI race, forcing even the most dominant players to adjust their financial expectations.